Literature DB >> 23463821

Appropriateness of Triple Therapy after COPD Exacerbation.

John R Manderville1.   

Abstract

Year:  2013        PMID： 23463821      PMCID： PMC3583780          DOI： 10.4212/cjhp.v66i1.1213

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  8 in total

1.  Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.

Authors:  Paul van der Valk; Evelyn Monninkhof; Job van der Palen; Gerhard Zielhuis; Cees van Herwaarden
Journal:  Am J Respir Crit Care Med       Date:  2002-09-05       Impact factor: 21.405

Review 2.  Methodological issues in therapeutic trials of COPD.

Authors:  S Suissa; P Ernst; K L Vandemheen; S D Aaron
Journal:  Eur Respir J       Date:  2008-01-23       Impact factor: 16.671

3.  Management of chronic obstructive pulmonary disease in patients admitted to a tertiary care centre for exacerbation of their disease.

Authors:  Roxanne Dault; Anne-Isabelle Dubé; Lucie Blais; Robert Boileau; Pierre Larrivée; Mario-Eddy Dumas; Marie-France Beauchesne
Journal:  Can J Hosp Pharm       Date:  2012-09

4.  Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction.

Authors:  A O'Brien; P Russo-Magno; A Karki; S Hiranniramol; M Hardin; M Kaszuba; C Sherman; S Rounds
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

5.  Susceptibility to exacerbation in chronic obstructive pulmonary disease.

Authors:  John R Hurst; Jørgen Vestbo; Antonio Anzueto; Nicholas Locantore; Hana Müllerova; Ruth Tal-Singer; Bruce Miller; David A Lomas; Alvar Agusti; William Macnee; Peter Calverley; Stephen Rennard; Emiel F M Wouters; Jadwiga A Wedzicha
Journal:  N Engl J Med       Date:  2010-09-16       Impact factor: 91.245

6.  Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Authors:  Shawn D Aaron; Katherine L Vandemheen; Dean Fergusson; François Maltais; Jean Bourbeau; Roger Goldstein; Meyer Balter; Denis O'Donnell; Andrew McIvor; Sat Sharma; Graham Bishop; John Anthony; Robert Cowie; Stephen Field; Andrew Hirsch; Paul Hernandez; Robert Rivington; Jeremy Road; Victor Hoffstein; Richard Hodder; Darcy Marciniuk; David McCormack; George Fox; Gerard Cox; Henry B Prins; Gordon Ford; Dominique Bleskie; Steve Doucette; Irvin Mayers; Kenneth Chapman; Noe Zamel; Mark FitzGerald
Journal:  Ann Intern Med       Date:  2007-02-19       Impact factor: 25.391

7.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

Review 8.  Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update.

Authors:  Denis E O'Donnell; Shaw Aaron; Jean Bourbeau; Paul Hernandez; Darcy D Marciniuk; Meyer Balter; Gordon Ford; Andre Gervais; Rogers Goldstein; Rick Hodder; Alan Kaplan; Sean Keenan; Yves Lacasse; Francois Maltais; Jeremy Road; Graeme Rocker; Don Sin; Tasmin Sinuff; Nha Voduc
Journal:  Can Respir J       Date:  2007-09       Impact factor: 2.409
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.